Your browser doesn't support javascript.
loading
Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).
Uchiyama, Kiyotaka; Mochizuki, Toshio; Shimada, Yosuke; Nishio, Saori; Kataoka, Hiroshi; Mitobe, Michihiro; Tsuchiya, Ken; Hanaoka, Kazushige; Ubara, Yoshifumi; Suwabe, Tatsuya; Sekine, Akinari; Nutahara, Kikuo; Tsuruya, Kazuhiko; Ishimura, Eiji; Nakatani, Shinya; Sofue, Tadashi; Tanaka, Satoshi; Narita, Ichiei; Maruyama, Shoichi; Horie, Shigeo; Muto, Satoru.
  • Uchiyama K; Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Mochizuki T; Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Shimada Y; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Nishio S; Intelligent Systems Laboratory, SECOM CO., LTD., Mitaka, Tokyo, Japan.
  • Kataoka H; Department of Medical Electronic Intelligence Management, Juntendo University Graduate School, Bunkyo, Tokyo, Japan.
  • Mitobe M; Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan.
  • Tsuchiya K; Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Hanaoka K; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Ubara Y; Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Suwabe T; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Sekine A; Department of Blood Purification, Tokyo Woman's Medical University, Tokyo, Japan.
  • Nutahara K; Department of General Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.
  • Tsuruya K; Department of Nephrology, Toranomon Hospital, Tokyo, Japan.
  • Ishimura E; Department of Nephrology, Toranomon Hospital, Tokyo, Japan.
  • Nakatani S; Department of Nephrology, Toranomon Hospital, Tokyo, Japan.
  • Sofue T; Department of Urology, Kyorin University School of Medicine, Tokyo, Japan.
  • Tanaka S; Department of Integrated Therapy for Chronic Kidney Disease, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Narita I; Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
  • Maruyama S; Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Horie S; Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Muto S; Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Kagawa, Japan.
Clin Exp Nephrol ; 25(9): 970-980, 2021 Sep.
Article en En | MEDLINE | ID: mdl-33928479
ABSTRACT

BACKGROUND:

Factors affecting decline in renal function and cyst growth in patients with autosomal polycystic kidney disease (ADPKD) are not fully described, particularly in Japan.

METHODS:

This was the first multi-facility, prospective, observational cohort study conducted in ADPKD patients at 14 centers in Japan. Patients in the J-PKD registry were assessed from December 2009 to June 2012 (follow-up until June 2017). Patients' data including estimated glomerular filtration rate (eGFR) and total kidney volume (TKV) were assessed initially and a maximum of five times annually. Contributing factors to eGFR decline and TKV growth were identified using multiple linear regression analysis.

RESULTS:

Of the 340 patients in the J-PKD registry, data analysis was performed for 192 patients in whom serial changes for both eGFR and TKV were obtained. eGFR slope, eGFR change, and TKV change values were as follows - 2.7 (- 4.2 to - 1.5) (ml/min/1.73 m2/year), - 5.0 (- 9.6 to - 2.3) (%/year), and 4.78 (0.86-8.22) (%/year), respectively. Lower high-density lipoprotein (HDL) cholesterol was an independent predictor of eGFR decline, using both eGFR slope and change (P = 0.04, P = 0.02, respectively), whereas lower hemoglobin and higher uric acid were significantly associated with greater eGFR change only (P = 0.02, P = 0.002, respectively). Younger age and higher fasting blood sugar were independent predictors of greater TKV change (P = 0.01, P = 0.02, respectively).

CONCLUSIONS:

This real-world study in Japan identified risk factors for renal function decline in ADPKD patients. These included lower HDL cholesterol, lower hemoglobin and higher uric acid for eGFR decline, and youth and higher blood sugar levels for TKV growth.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Riñón Poliquístico Autosómico Dominante / Riñón Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Riñón Poliquístico Autosómico Dominante / Riñón Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2021 Tipo del documento: Article